GovChime
Notice ID: 99d39fb9459d489089749fa826ed4021Award NoticeAwarded

Quetiapine Fumarate XR Tablets

Awarded on September 7, 2023. Full description on SAM.gov.

Awarded tounder SPE2D223D0012 (source: SAM.gov award notice)• $4.3M

Overview

Posted
October 7, 2026
Notice type
Award Notice
NAICS
325412: Pharmaceutical Preparation Manufacturing
Agency
Department of WarDEFENSE LOGISTICS AGENCY

Notice details

Office
TROOP SUPPORT MEDICAL.DLA TROOP SUPPORT
Place of performance
Hauppauge, New York, 11788
Last updated
Oct 28, 2026
First published
Last updated on SAM.gov
Award date
Sep 7, 2023
Award amount (SAM.gov award notice)
$4.3M

Identifiers

Solicitation number
SPE2D223D0012
Notice ID
99d39fb9459d489089749fa826ed4021
Award number (PIID)
SPE2D223D0012

Description

Modification SPE2D223D0012 P00009 to exercise Option Year 3.

Full description on SAM.gov

Award Overview

Award Number

SPE2D223D0012

Award Amount (SAM.gov award notice)

$4.3M

Award Date

Sep 7, 2023

Awardee

Awardee UEI

GQLDJJ8AQNN5

Awardee CAGE Code

1HT23

Awardee Address

Camarillo, CA 93012, UNITED STATES

Line Item Number

SPE2D223D0012

Original Solicitation

Notice ID: 99d39fb9459d489089749fa826ed4021

Posted Date: Oct 7, 2026

Original Response Deadline: Not specified

More From This Vendor

Top 5 most recent

5
  • SPE2D326F373X
    GOLDEN STATE MEDICAL SUPPLY, INC.
    Department of DefenseNAICS 325412
    $147.36Signed Aug 12, 2026
  • SPE2D326F373Z
    GOLDEN STATE MEDICAL SUPPLY, INC.
    Department of DefenseNAICS 325412
    $535.44Signed Aug 12, 2026
  • SPE2D326F375Z
    GOLDEN STATE MEDICAL SUPPLY, INC.
    Department of DefenseNAICS 325412
    $27.3Signed Aug 12, 2026
  • SPE2D326F359Y
    GOLDEN STATE MEDICAL SUPPLY, INC.
    Department of DefenseNAICS 325412
    $85.96Signed Aug 10, 2026
  • SPE2D326F357G
    GOLDEN STATE MEDICAL SUPPLY, INC.
    Department of DefenseNAICS 325412
    $133.86Signed Aug 7, 2026

Contacts

Contracting Officer

Primary Contact

Secondary Contact

Documents

Files (10)

  • MOD P00009 - Option Year 3.PDF.pdf

    18 KBAdded in Award Notice version 7Posted
    Download
  • MOD P00006 - Option Year Two - 18.Oct.2025 to 17.Oct.2026.pdf

    18 KBAdded in Award Notice version 7Posted
    Download
  • Signed MOD P0004 - Exercising Option 1 - Quetiapine Fumarate XR.pdf

    113 KBAdded in Award Notice version 5Posted
    Download
  • Amendment 0003 SPE2D2-23-R-0010.pdf

    333 KBAdded in Solicitation version 5Posted
    Download
  • Signed SPE2D223D0012 P00002 Quetiapine Fumarate XR.pdf

    117 KBAdded in Award Notice version 4Posted
    Download
  • Amendment 0002 SPE2D2-23-R-0010.pdf

    18 KBAdded in Solicitation version 4Posted
    Download
  • Signed SPE2D223D0012 P00001.pdf

    1009 KBAdded in Award Notice version 3Posted
    Download
  • Amendment 0001 SPE2D2-23-R-0010.pdf

    323 KBAdded in Solicitation version 3Posted
    Download
  • Signed Award SPE2D2-23-D-0012 Quetiapine Fumarate XR Tablets.pdf

    12 MBAdded in Award Notice version 2Posted
    Download
  • Quetiapine Fumarate XR Tablets National Contract Solicitation SPE2D223R0010.pdf

    1.4 MBAdded in Solicitation version 2Posted
    Download

Lifecycle

  1. 1
    Version 1Solicitation

    Quetiapine Fumarate XR Tablets

    Notice 5638f6e61f4442d28dd36c7811458ddd on SAM.gov

  2. 2
    Version 2Award Notice

    Type changed from Solicitation to Award Notice

    Quetiapine Fumarate XR Tablets

    Notice f68dae132da145539a004f5e4ee93c99 on SAM.gov

  3. 3
    Version 3Award Notice

    Quetiapine Fumarate XR Tablets

    Notice 937fd04ad7204c23a975ef7820fc01fc on SAM.gov

  4. 4
    Version 4Award Notice

    Quetiapine Fumarate XR Tablets

    Notice a89a6e6a15d348f98a72af085fae6da0 on SAM.gov

  5. 5
    Version 5Award Notice

    Quetiapine Fumarate XR Tablets

    Notice edc501f95a0344f6a2ddc6108ffaeee3 on SAM.gov

  6. 6
    Version 6Award Notice

    Quetiapine Fumarate XR Tablets

    Notice c5d7fc854a98440eb6cb141963bc8164 on SAM.gov

  7. 7
    Version 7Award NoticeCurrent

    Quetiapine Fumarate XR Tablets

    Notice 99d39fb9459d489089749fa826ed4021 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
SPE2D2-26-D-0004 Morphine IR & ER Tablets Award
-AwardedOpen
Modification P00010 SPE2D223D0002 is issued to invoke option year 4 for Bupropion HCL ER National Contract. Modification P00009 SPE2D223D0002 is issued to incorporate clause 52.222-90, Addressing DEI Discrimination by Federal Contractors (DEVIATION 2026-O0040, REVISION 1) (APR 2026). Modification P00008 SPE2D223D0002 is issued to invoke option year 3 for Bupropion HCL ER National Contract. Modification P00007 SPE2D223D0002 is issued in accordance with DoD Class Deviation 2025-O0003 and Class Deviation 2025-O0004 into subject solicitation. Modification P00006 SPE2D223D0002 is issued to invoke option year 2 for Bupropion HCL ER National Contract. Modification P00005 SPE2D223D0002 is issued to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders into subject solicitation. NATIONAL CONTRACT SPE2D2-23-D-0002 BUPROPION HCL ER
-AwardedOpen
MOD for Option Year Two (2) is attached.
-AwardedOpen
Modification to exercise option year 1.
-AwardedOpen
1. Option #1 is hereby executed for the period July 2, 2026 through July 1, 2027. 2. All other terms and conditions remain unchanged.
-AwardedOpen

Additional Details

Solicitation Number

SPE2D223D0012

Archive Date

Oct 17, 2029

Office Address

PHILADELPHIA, PA, 19111